Semaglutide Peptide Guide

Semaglutide is a long-acting GLP-1 receptor agonist with extensive human trial evidence for appetite reduction, weight loss, and improved blood sugar control. This page explains the practical takeaways people care about, plus the main safety considerations, in plain English.

What is Semaglutide?

Semaglutide is a modified peptide that acts like GLP-1, a natural gut hormone released after meals. GLP-1 helps the body release insulin when glucose is high, reduces glucagon, slows stomach emptying, and signals fullness to the brain. Semaglutide is engineered to last much longer than native GLP-1, so its effects are sustained.

Educational information only. Not medical advice.

Benefits

Mechanism of action

Primary pathways (studied):

Cell-level effects (studied):

System-level effects (studied):

Half-life

Half-life: About 1 week (long-acting).

Duration: Sustained activity across the week for long-acting formulations.

Peak time: Roughly 1 to 3 days after administration (varies).

Storage

Storage depends on formulation (lyophilized powder vs reconstituted solution) and the manufacturer. Follow the product label when available.

Reconstitution guide

For measurement math (mg, mL, and U-100 units), use:

Protocol overview

Protocol pages summarize common research-style structures and measurement concepts. They do not provide individualized instructions.

Educational information only. Not medical advice.

Research review and sources

Reviewed by: PeptideUniv Research Team

Updated: March 26, 2026

Human trial evidence exists, but the practical takeaways still depend on population, endpoint, and how long the compound has been studied.

Key research takeaways surfaced on this page

For educational and research purposes only. Not medical advice. Consult a licensed healthcare professional for personal guidance.